Richard Isaacson

Richard S. Isaacson, MD, is a Harvard-trained neurologist and world-renowned researcher in the field of Alzheimer’s prevention and treatment. He founded and directed the first Alzheimer’s Prevention Clinic (APC) in the U.S. in 2013 at Weill Cornell Medicine/New York-Presbyterian, where he also served as director of the neurology residency program, assistant dean of faculty development, and associate professor of neurology. Dr. Isaacson currently conducts research at the Institute for Neurodegenerative Diseases, Florida.

Leveraging his busy clinical practice and broad background in computer science, m-Health, biotechnology, and web development, Dr. Isaacson led interwoven clinical research and technology teams at the APC. His team rigorously evaluated the effects of personalized, evidence-based multi-modal interventions on cognition, serum/radiologic biomarkers of AD, and calculated AD and cardiovascular risk. He has published novel methods for using a precision medicine approach in real-world clinical practice of risk reduction for AD, and is currently funded by the NIH to create a digital therapeutic for AD prevention.

Before his tenure at Weill Cornell Medicine, Dr. Isaacson served as associate professor of clinical neurology, vice chair of education, and education director of the McKnight Brain Institute in the Department of Neurology at the University of Miami Miller School of Medicine. He completed his residency in neurology at Beth Israel Deaconess Medical Center/Harvard Medical School and his medical internship at Mount Sinai Medical Center in Miami Beach. Before he joined the University of Miami, he served as associate medical director of the Win Center for Alzheimer’s disease and Memory Disorders at Mount Sinai.